Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MD-0727 in Primary Hypercholesterolemia
NCT00404001Phase 2Completed
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypercholesterolemia comparing MD-0727 with Placebo (2 arms). Primary endpoints: Low Density Lipoprotein Cholesterol and Safety and Adverse Events. Started Nov 2006; status: completed.
02
Drugs
MD-0727
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00404001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404001.